![Cav-1 null mice are hyperphagic and have a normal capacity to absorb... | Download Scientific Diagram Cav-1 null mice are hyperphagic and have a normal capacity to absorb... | Download Scientific Diagram](https://www.researchgate.net/publication/11617945/figure/fig3/AS:601776776560670@1520486172840/Cav-1-null-mice-are-hyperphagic-and-have-a-normal-capacity-to-absorb-dietary-fat-A-a.png)
Cav-1 null mice are hyperphagic and have a normal capacity to absorb... | Download Scientific Diagram
![Felix WIELAND | Head of Department | prof. Dr. rer. nat. dipl. Chem. | Universität Heidelberg, Heidelberg | Center for Biochemistry (BZH) | Research profile - Page 2 Felix WIELAND | Head of Department | prof. Dr. rer. nat. dipl. Chem. | Universität Heidelberg, Heidelberg | Center for Biochemistry (BZH) | Research profile - Page 2](https://i1.rgstatic.net/ii/profile.image/273791167234051-1442288309226_Q512/Felix-Wieland-3.jpg)
Felix WIELAND | Head of Department | prof. Dr. rer. nat. dipl. Chem. | Universität Heidelberg, Heidelberg | Center for Biochemistry (BZH) | Research profile - Page 2
Viktoria Tierbach email address & phone number | GBG Forschungs GmbH Senior Clinical Project Manager contact information - RocketReach
Ioannis Gkantiragas email address & phone number | GBG Forschungs GmbH Senior Clinical Project Manager, PMP contact information - RocketReach
![Friedrich LOTTSPEICH | Head of Protein Analysis, retired 2013 | Dr. phil. Dr. med..habil. | Max Planck Institute of Biochemistry, München | MPIB | Department of Protein Analysis | Research profile - Page 2 Friedrich LOTTSPEICH | Head of Protein Analysis, retired 2013 | Dr. phil. Dr. med..habil. | Max Planck Institute of Biochemistry, München | MPIB | Department of Protein Analysis | Research profile - Page 2](https://i1.rgstatic.net/ii/profile.image/277666096795664-1443212164800_Q512/Friedrich-Lottspeich.jpg)
Friedrich LOTTSPEICH | Head of Protein Analysis, retired 2013 | Dr. phil. Dr. med..habil. | Max Planck Institute of Biochemistry, München | MPIB | Department of Protein Analysis | Research profile - Page 2
![A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) - ScienceDirect A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2059702922002319-gr1.jpg)
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) - ScienceDirect
![A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)☆ - ESMO Open A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)☆ - ESMO Open](https://www.esmoopen.com/cms/asset/28fe90d5-812f-4727-8b75-d1b652e00e67/gr2.jpg)
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)☆ - ESMO Open
Thomai Gkantiraga på LinkedIn: I didn't expect that someone could be filled with so many memories and… | 18 kommentarer
Protein subcomplexes in the GIC preparation. Left, GICs were isolated... | Download Scientific Diagram
![Dora KALOYANOVA | PhD | Utrecht University, Utrecht | UU | Department of Biochemistry and Cell Biology (DBC) | Research profile Dora KALOYANOVA | PhD | Utrecht University, Utrecht | UU | Department of Biochemistry and Cell Biology (DBC) | Research profile](https://i1.rgstatic.net/ii/profile.image/272476793995268-1441974938125_Q512/Dora-Kaloyanova.jpg)